A trial to study efficacy and Safety of boceprevir-Based Therapy in hepatitis C virus in genotype-1 treatment-Experienced Patients with Advanced Fibrosis/Cirrhosis: the Italian and Spanish Npp Early Access Program

Trial Profile

A trial to study efficacy and Safety of boceprevir-Based Therapy in hepatitis C virus in genotype-1 treatment-Experienced Patients with Advanced Fibrosis/Cirrhosis: the Italian and Spanish Npp Early Access Program

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2015

At a glance

  • Drugs Boceprevir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top